Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.02 (-1.94%)
Close on Nov 17, 2026Market cap $176.01MP/E –Yield –
Palisade Bio pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Palisade Bio's pe ratio was 0.8× on Oct 31, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Oct 31, 2022 | 0.8× | – |
See a number that looks wrong?